selected publications
-
chapter
-
conference paper
- Desempenho de ferramentas in silico: Avaliação de variantes de mutações missense do gene UGT1A1 2016
- Ugt1a1 gene variants and total bilirubin levels in healthy subjects and in Gilbert syndrome patients 2012
- Prediction of deleterious nsSNPs in human UGT1A1 gene by web available algorithm tools 2011
- Variação inter-individual nos níveis de bilirrubina: o papel dos factores genéticos e adquiridos. Bioanálise. 2011
- Influence of genetic and aquired factors that modify serum bilirubin levels in the portuguese population 2010
- UGT1A1 gene variations in individuals with and without clinical diagnosis of Gilbert Syndrome 2010
- Contribution of red cell mass and UGT1A1 alleles in serum bilirubin levels of the portuguese population. Molecular Genetics and Metabolism. 132-132. 2009
- Genetic and acquired factors that modulate serum bilirubin levels 2009
- Factores genéticos e ambientais que afectam os níveis séricos de bilirrubina na população portuguesa. Bioanálise. 26-27. 2008
- Haemorheological changes during recombinante human erythropoietin therapy in a rat model of renal failure induced by partial nephrectomy 2008
- Higher fibrinolytic and inflammatory markers are associated with central venous catheters use in chronic kidney disease patients under haemodialysis 2008
- Interference of environmental factors in serum bilirubin levels - a preliminary study 2008
- T-cell phenotype and inflammation in chronic kidney disease patients under haemodialysis and its relationship to resistance to rhEPO therapy 2008
- Altered erythrocyte membrane band 3 profile in chronic renal failure patients under haemodialysis 2007
- Band 3 as a marker of erythrocyte changes in chronic renal failure 2007
- Fibrinolytic activity and vascular access inchronic renal failure patients under haemodialysis 2007
- Fibrinolytic in chronic renal failure patients under haemodialysis and its retionship to recombinant human erythrpoietin resistance 2007
- Neuthrophil activation markers in chronic renal failure patients under haemodialysis and recombinant human erythropoietin 2007
- Co-existance of congenital red cell pyruvate kinase and band 3 deficiency. Blood. 2003
- Banda 3 profile as a marker of oxidative stress in hereditary spherocytosis. Blood. 1998
-
journal article
- A Microfluidic Deformability Assessment of Pathological Red Blood Cells Flowing in a Hyperbolic Converging Microchannel. Micromachines. 645. 2019
- Performance of in silico tools for the evaluation of UGT1A1 missense variants. Human Mutation. 1215-1225. 2015
- Bilirubin levels and redox status in a young healthy population. Acta Haematologica. 57-60. 2013
- Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects. Blood Cells, Molecules and Diseases. 166-172. 2012
- Bilirubin dependent on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index. American Journal of the Medical Sciences. 2011
- Variação inter-individual nos níveis de bilirrubina: o papel dos factores genéticos e adquiridos. Bioanálise. 5-13. 2011
- IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells, Molecules and Diseases. 2008
- Inflammation, T-Cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. Journal of Clinical Immunology. 2008
- Erythropoietin levels in the different clinical forms of hereditary spherocytosis. British Journal of Haematology. 2005
- Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. European Journal of Haematology. 2005
- Coexistence of congenital red cell pyruvate kinase and band 3 deficiency 2004